Abstract:A bioengineered dynamic tumor‐on‐a‐chip platform incorporating human‐derived platelet lysate hydrogels is developed to emulate in‐chip 3D tumor architecture, invasion, and drug response. The tumor inter‐heterogeneity mimicked by co‐culturing tumors with distinct metastatic ability with mesenchymal stem cells replicates the synergistic tumor‐stromal cell and cell‐extracellular matrix interactions, as well as low‐ and high‐metastatic tumor biomarkers in a fully human microenvironment. The coordinated migration of invasive tumor cells is a complex and dynamic mechanism driven by diverse cellular and molecular events. Unfortunately, the inherent heterogeneity within tumors raises multiple challenges in deciphering key biomarkers and novel therapeutic approaches to prevent tumor metastasis. Here, a microengineered tumor‐on‐a‐chip system incorporating human platelet lysate hydrogels is proposed to recreate the early metastatic process of tumor invasion and drug response. By co‐culturing human bone marrow mesenchymal stem cells with two tumor cell lines with distinct metastatic capability, the developed model can emulate the 3D tumor microarchitecture and inter‐heterogeneity regarding its intrinsic metastatic ability. The recreated microenvironment supports tumor and stromal cell movement, evidencing the synergistic tumor‐stromal cell and cell‐extracellular matrix interactions of an invading tumor. Through gene and protein expression analysis and exometabolomic profiling, this tumor‐on‐a‐chip platform provides evidence for the role of a dynamic environment as a key regulator of tumor metastatic ability. Additionally, the effect of doxorubicin treatment on tumor invasiveness and biomarker profile highlights the suitability of the established models for therapy assessment. Overall, this study presents a tumor‐on‐a‐chip model useful to pursue mechanistic studies on early metastatic events in a fully human‐derived microenvironment, while contributing with fundamental insights into biomolecular profiling.

Tumor‐On‐A‐Chip Models for Predicting In Vivo Nanoparticle Behavior

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system

Tumor-on-a-chip Platforms for Assessing Nanoparticle-Based Cancer Therapy.

Recapitulation of dynamic nanoparticle transport around tumors using a triangular multi-chamber tumor-on-a-chip

Tumor-on-a-chip: from bioinspired design to biomedical application

On-chip modeling of tumor evolution: Advances, challenges and opportunities

A Dynamic 3D Tumor Spheroid Chip Enables More Accurate Nanomedicine Uptake Evaluation

A Microfluidic Tumor‐on‐a‐Chip for Assessing Multifunctional Liposomes' Tumor Targeting and Anticancer Efficacy

Tumor-microenvironment-on-a-chip: the construction and application

Modelling cancer in microfluidic human organs-on-chips

A Hybrid In Silico and Tumor-on-a-Chip Approach to Model Targeted Protein Behavior in 3D Microenvironments

Tumors on chips: oncology meets microfluidics

Organ-on-chip systems as a model for nanomedicine

On-chip recapitulation of the tumor microenvironment: A decade of progress

Microfluidic modelling of the tumor microenvironment for anti-cancer drug development

3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (Adv. Healthcare Mater. 18/2023)

Improving tumor microenvironment assessment in chip systems through next-generation technology integration

Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation.

Tumor‐On‐A‐Chip Model Incorporating Human‐Based Hydrogels for Easy Assessment of Metastatic Tumor Inter‐Heterogeneity

Nanoparticle Accumulation and Penetration in 3D Tumor Models: the Effect of Size, Shape, and Surface Charge